| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |